TW200509918A - Treatment of depression and other affective disorders - Google Patents

Treatment of depression and other affective disorders

Info

Publication number
TW200509918A
TW200509918A TW093117156A TW93117156A TW200509918A TW 200509918 A TW200509918 A TW 200509918A TW 093117156 A TW093117156 A TW 093117156A TW 93117156 A TW93117156 A TW 93117156A TW 200509918 A TW200509918 A TW 200509918A
Authority
TW
Taiwan
Prior art keywords
depression
treatment
affective disorders
gaboxadol
pharmaceutical composition
Prior art date
Application number
TW093117156A
Other languages
English (en)
Inventor
Connie Sanchez
Bjarke Ebert
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58707228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200509918(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of TW200509918A publication Critical patent/TW200509918A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW093117156A 2003-06-25 2004-06-15 Treatment of depression and other affective disorders TW200509918A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300956 2003-06-25
DKPA200400016 2004-01-07

Publications (1)

Publication Number Publication Date
TW200509918A true TW200509918A (en) 2005-03-16

Family

ID=58707228

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093117156A TW200509918A (en) 2003-06-25 2004-06-15 Treatment of depression and other affective disorders

Country Status (10)

Country Link
KR (1) KR20060025192A (zh)
AR (1) AR047550A1 (zh)
CA (2) CA2529805A1 (zh)
CL (2) CL2004001607A1 (zh)
EA (1) EA200600101A1 (zh)
IS (1) IS8138A (zh)
ME (2) ME00030B (zh)
NO (1) NO20060229L (zh)
RS (1) RS20050911A (zh)
TW (1) TW200509918A (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3883566A4 (en) 2018-11-21 2022-09-07 Certego Therapeutics Inc. GABOXADOL FOR SUICIDE RISK REDUCTION AND RAPID DEPRESSION RELIEF
CA3182508A1 (en) 2020-05-20 2021-11-25 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Also Published As

Publication number Publication date
MEP1908A (xx) 2010-02-10
KR20060025192A (ko) 2006-03-20
CL2004001607A1 (es) 2005-05-27
AR047550A1 (es) 2006-01-25
ME00030B (me) 2010-06-10
IS8138A (is) 2005-11-21
RS20050911A (en) 2007-08-03
NO20060229L (no) 2006-01-16
CL2010000166A1 (es) 2010-07-02
EA200600101A1 (ru) 2006-06-30
CA2529805A1 (en) 2004-12-29
CA2692334A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
IL172631A0 (en) Gaboxadol for treating depression and other affective disorders
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
PL2134704T3 (pl) Związki i kompozycje pełniące rolę modulatorów aktywności GPR119
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
TW200616627A (en) New pharmaceutical compositions for the treatment of hyper-proliferative disorders
MX2007010560A (es) Roflumilast para el tratamiento de diabetes mellitus.
SG156641A1 (en) Compounds for nonsense suppression, and methods for their use
HK1100765A1 (en) Use of rotigotine for treating and preventing parkinson's plus syndrome
MX2011013032A (es) Inhibidores de fosfatidilinositol 3-cinasa.
MX2012004548A (es) Nuevas composiciones para prevenir y/o tratar transtornos degenerativos del sistema nervioso central.
CL2008003231A1 (es) Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura.
TW200716153A (en) Mitotic kinesin inhibitors and methods of use thereof
TW200509918A (en) Treatment of depression and other affective disorders
UA90656C2 (ru) Габоксадол для лечения депрессии
WO2009158387A3 (en) Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption
MX2010003615A (es) Tratamiento de desordenes neurologicos.
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
CL2009001113A1 (es) Compuestos derivados de 4,5-diarilpirrol-2-carboxamida; procedimiento de preparacion de estos; composicion farmaceutica que los comprende; uso en el tratamiento y/o prevencion de trastornos psiquiatricos, dependencia a sustancias, entre otras.
WO2009105218A3 (en) Propiophenone derivatives
TW200504016A (en) Inhibitors of monoamine uptake
UA97289C2 (ru) Соединения и их композиция как модуляторы gpr119 активности
EA200600183A1 (ru) Сочетание ингибитора обратного захвата серотонина и агомелатина